Efficacy and safety of ramucirumab and docetaxel in previously treated patients with squamous cell lung cancer: a multicenter retrospective cohort study.

Hayato KawachiMotohiro TamiyaKinnosuke MatsumotoAkihiro TamiyaTakafumi YanaseSatoshi TanizakiToru Kumagai

Published in: Investigational new drugs (2022)

For previously treated patients with Sq, the efficacy and safety of RAM/DOC therapy were confirmed in a real-world setting and were similar to non-Sq.

Keyphrases

squamous cell
newly diagnosed
clinical trial
cross sectional
squamous cell carcinoma
radiation therapy
mesenchymal stem cells
bone marrow